Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 306

1.

Effect of In Ovo Injection of L-Arginine in Different Chicken Embryonic Development Stages on Post-Hatchability, Immune Response, and Myo-D and Myogenin Proteins.

Subramaniyan SA, Kang DR, Park JR, Siddiqui SH, Ravichandiran P, Yoo DJ, Na CS, Shim KS.

Animals (Basel). 2019 Jun 14;9(6). pii: E357. doi: 10.3390/ani9060357.

2.

Glial injury in neurotoxicity after pediatric CD19-directed chimeric antigen receptor T cell therapy.

Gust J, Finney OC, Li D, Brakke HM, Hicks RM, Futrell RB, Gamble DN, Rawlings-Rhea SD, Khalatbari HK, Ishak GE, Duncan VE, Hevner RF, Jensen MC, Park JR, Gardner RA.

Ann Neurol. 2019 Jul;86(1):42-54. doi: 10.1002/ana.25502. Epub 2019 May 27.

PMID:
31074527
3.

Influence of rabeprazole and famotidine on pharmacodynamic profile of dual antiplatelet therapy in clopidogrel-sensitive patients: The randomized, prospective, PROTECT trial.

Ahn JH, Park Y, Bae JS, Jang JY, Kim KH, Kang MG, Koh JS, Park JR, Hwang SJ, Kwak CH, Hwang JY, Jeong YH.

Platelets. 2019 Apr 30:1-8. doi: 10.1080/09537104.2019.1609667. [Epub ahead of print]

PMID:
31037994
4.

Erratum to clinical efficacy of high-flow oxygen therapy through nasal cannula in patients with acute heart failure.

Kang MG, Kim K, Ju S, Park HW, Lee SJ, Koh JS, Hwang SJ, Hwang JY, Bae JS, Ahn JH, Jang JY, Park Y, Jeong YH, Kwak CH, Park JR.

J Thorac Dis. 2019 Mar;11(3):E65. doi: 10.21037/jtd.2019.03.59.

5.

Association between pulse pressure at discharge and clinical outcomes in patients with acute myocardial infarction: From the KAMIR-Korean-NIH registry.

Park HW, Kang MG, Kim K, Koh JS, Park JR, Hwang SJ, Kim HR, Jeong YH, Ahn JH, Jang JY, Kwak CH, Park Y, Hwang JY, Jeong MH, Kim HS, Yoon CH, Kim DI; KAMIR-Korean-NIH registry.

J Clin Hypertens (Greenwich). 2019 Jun;21(6):774-785. doi: 10.1111/jch.13534. Epub 2019 Apr 23.

6.

Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study.

Braunstein SE, London WB, Kreissman SG, Villablanca JG, Davidoff AM, DeSantes K, Castleberry RP, Murray K, Diller L, Matthay K, Cohn SL, Shulkin B, von Allmen D, Parisi MT, Van Ryn C, Park JR, La Quaglia MP, Haas-Kogan DA.

Pediatr Blood Cancer. 2019 Jul;66(7):e27736. doi: 10.1002/pbc.27736. Epub 2019 Apr 9.

PMID:
30968542
7.

Clinical efficacy of high-flow oxygen therapy through nasal cannula in patients with acute heart failure.

Kang MG, Kim K, Ju S, Park HW, Lee SJ, Koh JS, Hwang SJ, Hwang JY, Bae JS, Ahn JH, Jang JY, Park Y, Jeong YH, Kwak CH, Park JR.

J Thorac Dis. 2019 Feb;11(2):410-417. doi: 10.21037/jtd.2019.01.51. Erratum in: J Thorac Dis. 2019 Mar;11(3):E65.

8.

Predictors of differential response to induction therapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG).

Pinto N, Naranjo A, Hibbitts E, Kreissman SG, Granger MM, Irwin MS, Bagatell R, London WB, Greengard EG, Park JR, DuBois SG.

Eur J Cancer. 2019 May;112:66-79. doi: 10.1016/j.ejca.2019.02.003. Epub 2019 Apr 1.

PMID:
30947024
9.

Tie2 activation promotes choriocapillary regeneration for alleviating neovascular age-related macular degeneration.

Kim J, Park JR, Choi J, Park I, Hwang Y, Bae H, Kim Y, Choi W, Yang JM, Han S, Chung TY, Kim P, Kubota Y, Augustin HG, Oh WY, Koh GY.

Sci Adv. 2019 Feb 13;5(2):eaau6732. doi: 10.1126/sciadv.aau6732. eCollection 2019 Feb.

10.

Statistical Framework in Support of a Revised Children's Oncology Group Neuroblastoma Risk Classification System.

Naranjo A, Irwin MS, Hogarty MD, Cohn SL, Park JR, London WB.

JCO Clin Cancer Inform. 2018 Dec;2:1-15. doi: 10.1200/CCI.17.00140.

11.

ALK-Related Neuroblastic Tumor Susceptibility.

Greengard EG, Park JR.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.
2010 Jan 5 [updated 2019 Jan 17].

12.

Erratum to cardiac arrest due to coronary embolism from a metastatic sarcoma recovered through aspiration thrombectomy.

Kang MG, Kim K, Park HW, Koh JS, Park JR, Hwang SJ, Hwang JY.

J Thorac Dis. 2018 Nov;10(11):E791. doi: 10.21037/jtd.2018.10.77.

13.

Influence of Amlodipine on Haemostatic Measurements during Clopidogrel Treatment in Patients with Coronary Artery Disease.

Koh JS, Park Y, Ahn JH, Kang MG, Kim KH, Bae JS, Park HW, Jang JY, Park JR, Hwang SJ, Kwak CH, Hwang JY, Tantry US, Gurbel PA, Jeong YH.

Thromb Haemost. 2019 Feb;119(2):264-273. doi: 10.1055/s-0038-1676795. Epub 2019 Jan 4.

PMID:
30609441
14.

Synthesis of cosmetic grade TiO2-SiO2 core-shell powder from mechanically milled TiO2 nanopowder for commercial mass production.

Swain B, Park JR, Park KS, Lee CG.

Mater Sci Eng C Mater Biol Appl. 2019 Feb 1;95:95-103. doi: 10.1016/j.msec.2018.10.005. Epub 2018 Oct 3.

PMID:
30573275
15.

Improvement in Light Extraction Efficiency of InGaN/GaN Blue Light Emitting Diodes Using Sidewall Texturing.

Kim JY, Park JR, Kwon MK.

J Nanosci Nanotechnol. 2019 Apr 1;19(4):2346-2348. doi: 10.1166/jnn.2019.15975.

PMID:
30486996
16.

The challenge of defining "ultra-high-risk" neuroblastoma.

Morgenstern DA, Bagatell R, Cohn SL, Hogarty MD, Maris JM, Moreno L, Park JR, Pearson AD, Schleiermacher G, Valteau-Couanet D, London WB, Irwin MS.

Pediatr Blood Cancer. 2019 Apr;66(4):e27556. doi: 10.1002/pbc.27556. Epub 2018 Nov 26. Review.

PMID:
30479064
17.

Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children's Oncology Group Study ANBL0531.

Twist CJ, Naranjo A, Schmidt ML, Tenney SC, Cohn SL, Meany HJ, Mattei P, Adkins ES, Shimada H, London WB, Park JR, Matthay KK, Maris JM.

J Clin Oncol. 2019 Jan 10;37(2):115-124. doi: 10.1200/JCO.18.00419. Epub 2018 Nov 16.

PMID:
30444686
18.

Application of Titanium Dioxide (TiO₂)-Embedded Buoyant Photocatalyst Balls Using Expanded Polystyrene.

Joo JC, Kim GY, Ahn CH, Lee S, Park JR, Kim JK, Oh JM.

J Nanosci Nanotechnol. 2019 Feb 1;19(2):1151-1154. doi: 10.1166/jnn.2019.15936.

PMID:
30360222
19.

Development of Titanium Dioxide (TiO₂)-Embedded Buoyant Photocatalyst Balls Using Expanded Polystyrene.

Joo JC, Kim GY, Ahn CH, Lee S, Park JR, Kim JK.

J Nanosci Nanotechnol. 2019 Feb 1;19(2):1065-1068. doi: 10.1166/jnn.2019.15935.

PMID:
30360202
20.

Manufacture of Chimeric Antigen Receptor T Cells from Mobilized Cyropreserved Peripheral Blood Stem Cell Units Depends on Monocyte Depletion.

Künkele A, Brown C, Beebe A, Mgebroff S, Johnson AJ, Taraseviciute A, Rolczynski LS, Chang CA, Finney OC, Park JR, Jensen MC.

Biol Blood Marrow Transplant. 2019 Feb;25(2):223-232. doi: 10.1016/j.bbmt.2018.10.004. Epub 2018 Oct 10.

PMID:
30315942
21.

Neuroblastoma and Histone Demethylation.

DuBois SG, Park JR.

N Engl J Med. 2018 Oct 11;379(15):1476-1477. doi: 10.1056/NEJMcibr1806782. No abstract available.

PMID:
30304660
22.

Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources.

Elzembely MM, Park JR, Riad KF, Sayed HA, Pinto N, Carpenter PA, Baker KS, El-Haddad A.

J Glob Oncol. 2018 Sep;4:1-12. doi: 10.1200/JGO.17.00118.

23.

Late effects in high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell rescue.

Elzembely MM, Dahlberg AE, Pinto N, Leger KJ, Chow EJ, Park JR, Carpenter PA, Baker KS.

Pediatr Blood Cancer. 2019 Jan;66(1):e27421. doi: 10.1002/pbc.27421. Epub 2018 Aug 27.

PMID:
30151986
24.

Fabrication of dihydroxyflavone-conjugated hyaluronic acid nanogels for targeted antitumoral effect.

Choi YR, Kim HJ, Ahn GY, Lee MJ, Park JR, Jun DR, Ryu TK, Park JW, Shin E, Choi SW.

Colloids Surf B Biointerfaces. 2018 Nov 1;171:690-697. doi: 10.1016/j.colsurfb.2018.08.003. Epub 2018 Aug 6.

PMID:
30114654
25.

Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma.

DuBois SG, Mosse YP, Fox E, Kudgus RA, Reid JM, McGovern R, Groshen S, Bagatell R, Maris JM, Twist CJ, Goldsmith K, Granger MM, Weiss B, Park JR, Macy ME, Cohn SL, Yanik G, Wagner LM, Hawkins R, Courtier J, Lai H, Goodarzian F, Shimada H, Boucher N, Czarnecki S, Luo C, Tsao-Wei D, Matthay KK, Marachelian A.

Clin Cancer Res. 2018 Dec 15;24(24):6142-6149. doi: 10.1158/1078-0432.CCR-18-1381. Epub 2018 Aug 9.

PMID:
30093449
26.

Oxygen-Induced Retinopathy and Choroidopathy: In Vivo Longitudinal Observation of Vascular Changes Using OCTA.

Kim Y, Hong HK, Park JR, Choi W, Woo SJ, Park KH, Oh WY.

Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):3932-3942. doi: 10.1167/iovs.18-24320.

PMID:
30073364
27.

Cardiac arrest due to coronary embolism from a metastatic sarcoma recovered through aspiration thrombectomy.

Kang MG, Kim K, Park HW, Koh JS, Park JR, Hwang SJ, Hwang JY.

J Thorac Dis. 2018 Jun;10(6):E469-E472. doi: 10.21037/jtd.2018.05.133. No abstract available. Erratum in: J Thorac Dis. 2018 Nov;10(11):E791.

28.

Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931.

Ozkaynak MF, Gilman AL, London WB, Naranjo A, Diccianni MB, Tenney SC, Smith M, Messer KS, Seeger R, Reynolds CP, Smith LM, Shulkin BL, Parisi M, Maris JM, Park JR, Sondel PM, Yu AL.

Front Immunol. 2018 Jul 16;9:1641. doi: 10.3389/fimmu.2018.01641. eCollection 2018.

29.

A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931.

Ozkaynak MF, Gilman AL, London WB, Naranjo A, Diccianni MB, Tenney SC, Smith M, Messer KS, Seeger R, Reynolds CP, Smith LM, Shulkin BL, Parisi M, Maris JM, Park JR, Sondel PM, Yu AL.

Front Immunol. 2018 Jun 18;9:1355. doi: 10.3389/fimmu.2018.01355. eCollection 2018. Erratum in: Front Immunol. 2018 Jul 16;9:1641.

30.

Coronary artery calcium score in predicting periprocedural myocardial infarction in patients undergoing an elective percutaneous coronary intervention.

Kang MG, Kang Y, Jang HG, Kim K, Koh JS, Park JR, Hwang SJ, Hwang JY, Bae JS, Ahn JH, Jang JY, Park Y, Jeong YH, Kwak CH, Park HW.

Coron Artery Dis. 2018 Nov;29(7):589-596. doi: 10.1097/MCA.0000000000000651.

PMID:
29965838
31.

Normal reference values of diastolic strain rate in healthy individuals: Chronological trends and the comparison according to genders.

Sun BJ, Park JH, Kim J, Choi JO, Lee JH, Shin MS, Kim MJ, Jung HO, Park JR, Sohn IS, Kim H, Kim HK, Cho GY, Park JS, Shim CY, Shin SH, Kim KH, Kim WS, Park SW.

Echocardiography. 2018 Oct;35(10):1533-1541. doi: 10.1111/echo.14053. Epub 2018 Jun 19.

PMID:
29920763
32.

L-carnosine induces apoptosis/cell cycle arrest via suppression of NF-κB/STAT1 pathway in HCT116 colorectal cancer cells.

Lee J, Park JR, Lee H, Jang S, Ryu SM, Kim H, Kim D, Jang A, Yang SR.

In Vitro Cell Dev Biol Anim. 2018 Aug;54(7):505-512. doi: 10.1007/s11626-018-0264-4. Epub 2018 Jun 4.

PMID:
29869056
33.

Fabrication and optimization of Nanodiamonds-composited poly(ε-caprolactone) fibrous matrices for potential regeneration of hard tissues.

Ahn GY, Ryu TK, Choi YR, Park JR, Lee MJ, Choi SW.

Biomater Res. 2018 May 30;22:16. doi: 10.1186/s40824-018-0126-x. eCollection 2018.

34.

Early IV-injected human dermis-derived mesenchymal stem cells after transient global cerebral ischemia do not pass through damaged blood-brain barrier.

Ahn JH, Chen BH, Park JH, Shin BN, Lee TK, Cho JH, Lee JC, Park JR, Yang SR, Ryoo S, Shin MC, Cho JH, Kang IJ, Lee CH, Hwang IK, Kim YM, Won MH.

J Tissue Eng Regen Med. 2018 Jul;12(7):1646-1657. doi: 10.1002/term.2692. Epub 2018 Jun 3.

PMID:
29763986
35.

Poly(2-oxazoline) Hydrogels: State-of-the-Art and Emerging Applications.

Dargaville TR, Park JR, Hoogenboom R.

Macromol Biosci. 2018 Jun;18(6):e1800070. doi: 10.1002/mabi.201800070. Epub 2018 May 7. Review.

PMID:
29736908
36.

A Rare Case of Left Ventricular Noncompaction in LEOPARD Syndrome.

Kim K, Kang MG, Park HW, Koh JS, Park JR, Hwang SJ, Hwang JY.

J Cardiovasc Ultrasound. 2018 Mar;26(1):43-44. doi: 10.4250/jcu.2018.26.1.43. Epub 2018 Mar 28. No abstract available.

37.

Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial.

Pinto N, DuBois SG, Marachelian A, Diede SJ, Taraseviciute A, Glade Bender JL, Tsao-Wei D, Groshen SG, Reid JM, Haas-Kogan DA, Reynolds CP, Kang MH, Irwin MS, Macy ME, Villablanca JG, Matthay KK, Park JR.

Pediatr Blood Cancer. 2018 Jul;65(7):e27023. doi: 10.1002/pbc.27023. Epub 2018 Mar 30.

38.

Door-to-balloon time and cardiac mortality in acute myocardial infarction by total occlusion of the left circumflex artery.

Kang MG, Kim K, Park HW, Koh JS, Park JR, Hwang SJ, Ahn JH, Park Y, Jeong YH, Kwak CH, Jeong MH, Chae SC, Kim HS, Kim YJ, Cho MC, Kim CJ, Hwang JY.

Coron Artery Dis. 2018 Aug;29(5):409-415. doi: 10.1097/MCA.0000000000000616.

PMID:
29570469
39.

Lymphocyte apheresis for chimeric antigen receptor T-cell manufacturing in children and young adults with leukemia and neuroblastoma.

Ceppi F, Rivers J, Annesley C, Pinto N, Park JR, Lindgren C, Mgebroff S, Linn N, Delaney M, Gardner RA.

Transfusion. 2018 Jun;58(6):1414-1420. doi: 10.1111/trf.14569. Epub 2018 Mar 13.

PMID:
29536556
40.

Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients.

Depuydt P, Boeva V, Hocking TD, Cannoodt R, Ambros IM, Ambros PF, Asgharzadeh S, Attiyeh EF, Combaret V, Defferrari R, Fischer M, Hero B, Hogarty MD, Irwin MS, Koster J, Kreissman S, Ladenstein R, Lapouble E, Laureys G, London WB, Mazzocco K, Nakagawara A, Noguera R, Ohira M, Park JR, Pötschger U, Theissen J, Tonini GP, Valteau-Couanet D, Varesio L, Versteeg R, Speleman F, Maris JM, Schleiermacher G, De Preter K.

J Natl Cancer Inst. 2018 Oct 1;110(10):1084-1093. doi: 10.1093/jnci/djy022.

41.

MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children's oncology group.

Niemas-Teshiba R, Matsuno R, Wang LL, Tang XX, Chiu B, Zeki J, Coburn J, Ornell K, Naranjo A, Van Ryn C, London WB, Hogarty MD, Gastier-Foster JM, Look AT, Park JR, Maris JM, Cohn SL, Seeger RC, Asgharzadeh S, Ikegaki N, Shimada H.

Oncotarget. 2017 Dec 15;9(5):6416-6432. doi: 10.18632/oncotarget.23740. eCollection 2018 Jan 19.

42.

Long-term Prognosis and Clinical Characteristics of Patients with Newly Diagnosed Diabetes Mellitus Detected after First Acute Myocardial Infarction: from KAMIR-NIH Registry.

Park HW, Kang MG, Kim K, Koh JS, Park JR, Jeong YH, Ahn JH, Jang JY, Kwak CH, Park Y, Jeong MH, Kim YJ, Cho MC, Kim CJ, Hwang JY; KAMIR-NIH registry.

Korean Circ J. 2018 Feb;48(2):134-147. doi: 10.4070/kcj.2017.0174.

43.

Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial.

de Alarcon PA, Matthay KK, London WB, Naranjo A, Tenney SC, Panzer JA, Hogarty MD, Park JR, Maris JM, Cohn SL.

Lancet Child Adolesc Health. 2018 Jan;2(1):25-34. doi: 10.1016/S2352-4642(17)30130-X. Epub 2017 Nov 3.

44.

Pembrolizumab for Refractory Metastatic Myxofibrosarcoma: A Case Report.

Song HN, Kang MG, Park JR, Hwang JY, Kang JH, Lee WS, Lee GW.

Cancer Res Treat. 2018 Oct;50(4):1458-1461. doi: 10.4143/crt.2017.529. Epub 2018 Jan 22.

45.

Predictors of response, progression-free survival, and overall survival using NANT Response Criteria (v1.0) in relapsed and refractory high-risk neuroblastoma.

Villablanca JG, Ji L, Shapira-Lewinson A, Marachelian A, Shimada H, Hawkins RA, Pampaloni M, Lai H, Goodarzian F, Sposto R, Park JR, Matthay KK.

Pediatr Blood Cancer. 2018 May;65(5):e26940. doi: 10.1002/pbc.26940. Epub 2018 Jan 19.

PMID:
29350464
46.

HIMH0021 attenuates ethanol-induced liver injury and steatosis in mice.

Lee Y, Kwon DJ, Kim YH, Ra M, Heo SI, Ahn WG, Park JR, Lee SR, Kim KH, Kim SY.

PLoS One. 2017 Nov 1;12(11):e0185134. doi: 10.1371/journal.pone.0185134. eCollection 2017.

47.

Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group.

Erbe AK, Wang W, Carmichael L, Kim K, Mendonça EA, Song Y, Hess D, Reville PK, London WB, Naranjo A, Hank JA, Diccianni MB, Reisfeld RA, Gillies SD, Matthay KK, Cohn SL, Hogarty MD, Maris JM, Park JR, Ozkaynak MF, Gilman AL, Yu AL, Sondel PM.

Clin Cancer Res. 2018 Jan 1;24(1):189-196. doi: 10.1158/1078-0432.CCR-17-1767. Epub 2017 Oct 2.

48.

Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN/HR-NBL1 and COG-A3973 trials.

Ladenstein R, Lambert B, Pötschger U, Castellani MR, Lewington V, Bar-Sever Z, Oudoux A, Śliwińska A, Taborska K, Biassoni L, Yanik GA, Naranjo A, Parisi MT, Shulkin BL, Nadel H, Gelfand MJ, Matthay KK, Park JR, Kreissman SG, Valteau-Couanet D, Boubaker A.

Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):292-305. doi: 10.1007/s00259-017-3829-7. Epub 2017 Sep 23.

49.

Validation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children's Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1.

Yanik GA, Parisi MT, Naranjo A, Nadel H, Gelfand MJ, Park JR, Ladenstein RL, Poetschger U, Boubaker A, Valteau-Couanet D, Lambert B, Castellani MR, Bar-Sever Z, Oudoux A, Kaminska A, Kreissman SG, Shulkin BL, Matthay KK.

J Nucl Med. 2018 Mar;59(3):502-508. doi: 10.2967/jnumed.117.195883. Epub 2017 Sep 8.

50.

Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trials.

London WB, Bagatell R, Weigel BJ, Fox E, Guo D, Van Ryn C, Naranjo A, Park JR.

Cancer. 2017 Dec 15;123(24):4914-4923. doi: 10.1002/cncr.30934. Epub 2017 Sep 8. Review.

Supplemental Content

Support Center